Hamps Bio Limited (BOM:544312)
23.00
-1.50 (-6.12%)
At close: Aug 17, 2026
Hamps Bio Market Cap
Hamps Bio has a market cap or net worth of 200.38 million as of August 18, 2026. Its market cap has decreased by -20.44% in one year.
Market Cap
200.38M
Enterprise Value
267.51M
Revenue
84.75M
Ranking
n/a
PE Ratio
n/a
Stock Price
23.00
ChartMarket Cap Chart
Since December 20, 2024, Hamps Bio's market cap has decreased from 443.18M to 200.38M, a decrease of -54.79%. That is a compound annual growth rate of -38.05%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 17, 2026 | 200.38M | 15.00% |
| Dec 29, 2025 | 174.24M | -51.61% |
| Dec 31, 2024 | 360.11M | -18.74% |
| Dec 20, 2024 | 443.18M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Gujarat Terce Laboratories | 309.70M |
| Welcure Drugs and Pharmaceuticals | 296.63M |
| Deccan Health Care | 291.65M |
| Cian Healthcare | 238.75M |
| Rekvina Laboratories | 235.94M |
| Colinz Laboratories | 203.34M |
| Add-Shop E-Retail | 180.92M |
| Zenith Healthcare | 165.52M |